Trypanosoma brucei in Cattle and Horses: Nagana, African Trypanosomiasis, Tsetse Fly Transmission, and Diagnosis
Etiology and Taxonomy
Trypanosoma brucei is a uniflagellate protozoan parasite of the order Kinetoplastida, family Trypanosomatidae. The organism is classified into three subspecies based on host range, geographic distribution, and pathogenicity. Trypanosoma brucei brucei is the primary causative agent of nagana in cattle, horses, and other domestic livestock in sub-Saharan Africa. The other subspecies, T. b. gambiense and T. b. rhodesiense, are predominantly human pathogens causing African sleeping sickness and are not discussed in this veterinary context except to note that T. b. brucei is non-infective to humans due to sensitivity to human serum trypanolytic factors. The subspecies are morphologically indistinguishable, and differentiation relies on molecular characterization, host susceptibility, and epidemiological context.
The parasite exhibits a digenetic life cycle alternating between the mammalian host and the tsetse fly vector (Glossina spp.). Within the mammalian host, the organism exists as a pleomorphic trypomastigote in blood, lymph, and tissue fluids. Two distinct morphological forms occur in the mammalian bloodstream: the long, slender form with a free flagellum, which undergoes rapid division, and the short, stumpy form, which is pre-adapted for transmission and is non-dividing. The stumpy form is the stage infectious to the tsetse fly upon ingestion.
Epidemiology: Trypanosoma brucei Nagana African Trypanosomiasis Tsetse Fly Cattle Horses
Nagana, derived from the Zulu word meaning "to be low or depressed," is a wasting disease of livestock caused by T. b. brucei and related species such as T. vivax and T. congolense. The disease is endemic across 36 to 38 sub-Saharan African countries, corresponding to the distribution of tsetse flies of the genus Glossina. This distribution covers approximately 10 million square kilometers, placing an estimated 50 to 60 million cattle and a substantial equine population at risk.
The epidemiology of T. brucei infection in cattle and horses is intrinsically linked to the ecology of the tsetse fly vector. Glossina species inhabit riverine, woodland, and savannah ecosystems. The vector exhibits a restricted flight range and feeds predominantly on large mammals. Transmission is cyclical, with the parasite undergoing developmental stages in the fly midgut and salivary glands over a period of 18 to 35 days depending on ambient temperature. After this extrinsic incubation period, the metacyclic trypomastigote stage is inoculated into a new mammalian host during a subsequent blood meal.
Cattle serve as major reservoir hosts for T. b. brucei. In endemic regions, the prevalence of infection in cattle herds can range from 10 to over 50 percent depending on tsetse challenge intensity, animal breed, and control interventions. Horses are highly susceptible and develop severe disease with high mortality if untreated. The presence of game animals, particularly wild bovids and suids, constitutes a sylvatic reservoir that complicates eradication efforts. Mechanical transmission by other hematophagous insects such as tabanid flies (horse flies) and Stomoxys species (stable flies) has been documented but is less epidemiologically significant than cyclical transmission.
Pathogenesis and Clinical Signs in Cattle
Upon inoculation of metacyclic trypomastigotes into the dermis, a local inflammatory response occurs, forming a trypanosomal chancre at the bite site. The parasites enter the lymphatic system and then the bloodstream, initiating a systemic infection. The pathogenesis of nagana is multifactorial and involves immune evasion through antigenic variation, immune complex deposition, and the release of lytic enzymes.
The variable surface glycoprotein (VSG) coat covering the parasite is the primary target of the host humoral immune response. The parasite genome contains hundreds of VSG genes, and periodic switching of the expressed VSG allows the population to evade antibody-mediated clearance. This process results in successive waves of parasitemia, each wave representing a new antigenic variant. The host immune system is progressively exhausted, and immunosuppression ensues.
Clinical manifestations in cattle are chronic and progressive. Early signs include intermittent pyrexia (spiking fevers coinciding with parasitemic waves), anemia, and lymphadenopathy. Anemia in cattle is predominantly hemolytic due to erythrocyte destruction by parasite-derived enzymes and immune-mediated mechanisms. As the disease advances, affected animals exhibit weight loss, decreased milk production, reduced fertility, abortion, and progressive emaciation. Ocular signs including corneal opacity and lacrimation are frequently reported. The disease course in cattle is often protracted over weeks to months, and many animals become chronically infected carriers, serving as reservoirs for further transmission. Mortality in untreated naive herds can exceed 50 percent.
Pathogenesis and Clinical Signs in Horses
Horses are highly susceptible to T. b. brucei infection, and the disease in equids is more acute and severe than in cattle. The incubation period ranges from 5 to 14 days. Initial signs include high fever (40 to 41 degrees Celsius), depression, and anorexia. Edema of the ventral abdomen, prepuce, scrotum, and limbs is a characteristic feature in horses. Petechial hemorrhages on the conjunctival and oral mucous membranes are common.
Neurological signs are frequent in equine trypanosomiasis and may include ataxia, circling, head pressing, and paralysis. Anemia develops rapidly and is severe. The disease progresses to emaciation, debilitation, and death within 2 to 4 weeks if left untreated. Abortion is common in pregnant mares. Unlike cattle, chronic asymptomatic carriage is rare in horses; most infected animals succumb to the acute disease. The pathophysiology in horses involves extensive vascular damage, disseminated intravascular coagulation, and profound immunosuppression.
Pathology
Gross pathological findings in cattle and horses infected with T. b. brucei include generalized lymphadenopathy, splenomegaly, hepatomegaly, and serous atrophy of pericardial and omental fat. Petechial and ecchymotic hemorrhages are present on serosal surfaces and endocardium. The bone marrow may appear pale and gelatinous due to anemia. In horses, subcutaneous edema and hydropericardium are prominent.
Histological lesions include lymphoplasmacytic and histiocytic infiltrates in the spleen, lymph nodes, liver, and bone marrow. Glomerulonephritis due to immune complex deposition is frequently observed. Myocarditis and meningoencephalitis are common in horses. In chronic cases, lymphoid depletion and fibrosis of lymphoid organs indicate terminal immunosuppression.
Diagnosis
Accurate diagnosis of Trypanosoma brucei nagana African trypanosomiasis tsetse fly cattle horses requires a combination of parasitological, serological, and molecular methods. The timing of sample collection relative to parasitemic waves is critical for direct detection methods.
Parasitological Methods
Microscopic examination of Giemsa-stained thin and thick blood smears remains the most widely used diagnostic technique in field settings. The long slender and short stumpy trypomastigotes are identifiable by their undulating membrane, free flagellum, elongated body, and centrally located nucleus with a kinetoplast at the posterior end. Parasitemia in cattle is often low and fluctuating, necessitating concentration techniques.
The hematocrit centrifugation technique (HCT), also known as the Woo method, involves centrifugation of blood in microhematocrit tubes and examination of the buffy coat layer for motile parasites. This method concentrates trypanosomes and increases sensitivity compared to direct smear examination. The miniature anion-exchange centrifugation technique (mAECT) uses ion-exchange chromatography to separate trypanosomes from blood cells, further improving detection sensitivity. Dark-field or phase-contrast microscopy can be used to visualize live, motile organisms in fresh blood preparations.
Serological Methods
Serological testing detects antibodies against T. brucei antigens, but cannot distinguish current infection from past exposure. The indirect fluorescent antibody test (IFAT) and enzyme-linked immunosorbent assay (ELISA) are the most commonly employed serological platforms. Commercial ELISA kits for trypanosome antibody detection use crude lysate or recombinant antigens. The card agglutination test for trypanosomiasis (CATT) is a rapid field test but is more commonly used for human trypanosomiasis. Cross-reactivity with other trypanosome species (e.g., T. vivax, T. congolense) is a known limitation of serological tests.
Molecular Diagnostics
Polymerase chain reaction (PCR) is the gold standard for molecular detection of T. brucei in livestock. Targeted genetic loci include the internal transcribed spacer 1 (ITS1) region of the ribosomal RNA gene cluster and the satellite DNA repeat sequences. PCR assays targeting the ITS1 region can discriminate between T. brucei, T. vivax, and T. congolense based on amplicon size differences. Real-time quantitative PCR (qPCR) using SYBR Green or TaqMan probes offers higher sensitivity and quantitation of parasitemia.
Loop-mediated isothermal amplification (LAMP) assays have been developed for field-based molecular detection without the need for thermal cyclers. LAMP targets include the serum resistance-associated (SRA) gene for T. b. rhodesiense and the 5.8S ribosomal RNA gene for generic trypanosome detection. Sensitivity of LAMP assays approaches that of conventional PCR.
Sample types suitable for molecular testing include whole blood preserved in EDTA, buffy coat, and dried blood spots on filter paper. DNA extraction from filter paper is performed using commercial silica membrane-based kits.
Diagnostic Differentiation
Nagana must be differentiated from other livestock diseases that cause fever, anemia, and wasting. Differential diagnoses include anaplasmosis caused by Anaplasma marginale in cattle, theileriosis, babesiosis, and nutritional deficiencies. In horses, differentials include equine infectious anemia (EIA), piroplasmosis as caused by Babesia caballi, and other causes of febrile hemolytic disease.
flowchart TD
A[Clinical Suspicion: Fever, Anemia, Emaciation], > B{Sample Collection}
B, > C[Whole Blood EDTA]
B, > D[Serum]
B, > E[Dried Blood Spot]
C, > F{Parasitology}
F, > G[Giemsa Smear]
F, > H[Hematocrit Centrifugation / Buffy Coat]
G, > I[Positive: Trypomastigotes]
H, > I
I, > J[Confirm with PCR]
J, > K[ITS1 PCR / qPCR]
K, > L[Species Identification]
D, > M{Serology}
M, > N[ELISA / IFAT]
N, > O[Antibody Detection]
E, > P{Direct Molecular}
P, > Q[DNA Extraction]
Q, > L
L, > R[Definitive Diagnosis]
O, > R
Treatment
Treatment of nagana relies on trypanocidal drugs. Diminazene aceturate is the drug of choice for treating T. b. brucei infections in cattle. It is administered as a single intramuscular injection at a dosage of 3.5 to 7.0 mg/kg body weight. Diminazene is not recommended for horses due to severe local reactions and neurotoxicity.
Isometamidium chloride is used both therapeutically and prophylactically in cattle at a dose of 0.25 to 1.0 mg/kg given intramuscularly. The prophylactic effect lasts 1 to 4 months depending on tsetse challenge. In horses, suramin is the preferred therapeutic agent. Suramin is administered intravenously at a dose of 10 mg/kg, with a second dose given 7 days later. Suramin is effective against early-stage infections but does not cross the blood-brain barrier and is ineffective against central nervous system involvement.
Quinapyramine sulfate and quinapyramine chloride are alternative trypanocides used in horses, but resistance to these compounds is widespread. Drug resistance is a growing problem in many endemic regions, particularly against diminazene and isometamidium. Resistance is mediated by reduced drug uptake and altered drug target expression.
Control and Prevention
Control of nagana involves integrated vector management and chemoprophylaxis. Tsetse fly control strategies include insecticide-treated targets (blue-black cloth panels impregnated with pyrethroids), insecticide-treated cattle (pour-on formulations), and sequential aerial spraying in riverine habitats. Sterile insect technique (SIT) has been used in targeted eradication programs on Zanzibar and in the Okavango Delta.
Chemoprophylaxis with isometamidium chloride is widely practiced in cattle. Strategic treatment during the dry season when tsetse fly density is lower can reduce parasite transmission. Movement controls and quarantine of infected animals prevent disease spread to trypanosome-free zones.
Breeding for trypanotolerance is a sustainable control approach. Trypanotolerant cattle breeds such as N'Dama and West African Shorthorn exhibit lower parasitemia and milder clinical signs. The genetic basis of trypanotolerance involves quantitative trait loci associated with control of parasitemia and anemia.
No effective vaccine exists for T. brucei due to antigenic variation of the VSG coat. Research efforts focus on conserved invariant surface glycoproteins (ISGs) and subdominant antigens as potential vaccine candidates.
Conclusion
Trypanosoma brucei remains one of the most economically significant livestock pathogens in sub-Saharan Africa, causing nagana in cattle and horses. The tsetse fly vector, the parasite's sophisticated antigenic variation system, and the lack of a vaccine present formidable challenges to control. Accurate diagnosis requires integration of parasitological, serological, and molecular methods, with PCR-based assays providing the highest sensitivity and species-level discrimination. Sustainable control depends on vector management, trypanotolerant cattle utilization, and careful drug stewardship to delay the emergence of resistance.
References
Radostits OM, Gay CC, Hinchcliff KW, Constable PD. Veterinary Medicine: A Textbook of the Diseases of Cattle, Horses, Sheep, Pigs and Goats. 10th ed. Saunders Elsevier; 2007.
Taylor MA, Coop RL, Wall RL. Veterinary Parasitology. 4th ed. Wiley Blackwell; 2016.
Desquesnes M. Livestock Trypanosomoses and Their Vectors in Latin America. World Organisation for Animal Health (OIE); 2004.
World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.4.14: Trypanosomosis (tsetse-transmitted). 2022.
Holmes PH. Pathophysiology of parasitic infections. Parasitology. 1987;94 Suppl:S29-51.
Van den Bossche P, de La Rocque S, Hendrickx G, Bouyer J. A changing environment and the epidemiology of tsetse-transmitted livestock trypanosomiasis. Trends in Parasitology. 2010;26(5):236-243.